Wednesday 02 April 2025
Internal Reference Number: FOI_8296
Date Request Received: 20/11/2024 00:00:00
Date Request Replied To: 16/01/2025 00:00:00
This response was sent via: By Email
Request Summary: medical retina services
Request Category: Companies
| Question Number 1: Medical retina services - Wet AMD and other anti VEGf treated condition, covering demand, capacity, and delivery For the financial years 2022/23, 2023/24 and current YTD, how many referrals have you received for wet AMD, diabetic macular oedema and retinal vein occlusion (Anti VEGf services) or perhaps referred to as medical retina? | |
| Answer To Question 1: We are unable to accurately answer this question as the referral data we collect does not break down to subspecialty level. For Medical retina (Excluding Wet AMD) we can make an assumption on number of referrals from New patient attendances: 2022 = 818 2023 = 745 2024 to date = 670 For Diabetic Retinopathy the same for New patient attendances: 2022 = 182 2023 = 202 2024 to date = 154 For the following we can only identify them through the number treated with Anti VEGf. Retinal Vein Occlusion (injected) 2022 = 194 patients (651 injections) 2023= 255 patients (969 Injections) 2024 to end of March = 166 patients (224 injections) The following are the number of injections given but each patient can have multiple injections as a series of treatments: Number of injections (NOT patients) for Wet AMD 2022= 2114 2023=1650 2024 to end of March = 337 Number of injections (NOT patients) for Diabetic Macular Oedema 2022= 61 2023=305 2024 to end of March = 51 The total number of injections given in those years for all conditions is 2022=3648 2023=5427 2024 until end of March = 1259 | |
| Question Number 2: For the financial years 2022/23, 2023/24 and current YTD, how many referrals have you rejected as unsuitable or undeliverable by your Trust? | |
| Answer To Question 2: Unable to answer as rejected referrals are not recorded onto a system that can be queried retrospectively to count how many there have been. | |
| Question Number 3: For the financial years 2022/23, 2023/24 and current YTD, how many referrals have you received, triaged, booked and completed first assessment and treatment within the 2 week RTT advised by NICE and the college of ophthalmologists? We are looking for your Trust performance data against the 14 day standard as a % by month for the periods - 2023/24 and 2024/25 | |
| Answer To Question 3: Please see our response to question 3, 4 and 5 in the spreadsheet attached. To accompany this answer to question 3 please also see the documents listed below:  FOI_8296 - Medical Retina Services responses to Q3, 4 and 5.xlsx | |
| Question Number 4: How many patients are currently on a waiting list for an appointment for first assessment and or treatment ? How many have breached the 2 week RTT? | |
| Answer To Question 4: See response to Q3 | |
| Question Number 5: How many patients are currently on a waiting list for a follow up appointment and treatment? How many of these have waited longer than the requested call back date stated as an outcome of their last assessment? (Ie overdue?) How many are overdue by more than one month? (We exclude from this any patients who have cancelled / DNA'd or are unable to attend an appointment that has been offered) | |
| Answer To Question 5: See response to Q3 | |
| Question Number 6: Which drugs are your preferred for a new patient? Which drugs do you still use for follow-up patients? | |
| Answer To Question 6: We offer licensed drugs including Vabysmo and Eylea , as per NICE guidelines and ICB specifications. | |
| Question Number 7: Does your trust follow a see and treat "one stop" clinic format? | |
| Answer To Question 7: Yes | |
| Question Number 8: Does your trust follow treat and extend protocols where clinically appropriate? | |
| Answer To Question 8: Yes | |
| Question Number 9: How many patients have you certificated as sight impaired or severely sight impaired in the FYs 2022/23, 2023/24 and year to date due to Wet AMD? | |
| Answer To Question 9: 2022 SSI - wet AMD - 27 Patients SI - wet AMD - 28 Patients 2023 SSI - wet AMD - 24 Patients SI - wet AMD 24 Patients 2024 SSI - wet AMD - 13 Patients SI - wet AMD - 17 Patients | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
